Clinical Trials Logo

Axial Spondyloarthritis clinical trials

View clinical trials related to Axial Spondyloarthritis.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06072859 Enrolling by invitation - Clinical trials for Axial Spondyloarthritis

The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)

Start date: September 21, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to learn about the ease of using a humidified fragrant citrus forest oil, along with a virtual simulation of a forest environment (i.e., with sights and sounds of nature using a personal tablet Surface Pro 3 with headphones, to learn more about how these two aspects of the simulated forest immersion therapy (SFIT) may improve pain, anxiety, blood-pressure, and heart rate related to Axial Spondyloarthritis. The investigators hope to learn how well SFIT may impact pain levels, feelings of calm, as well as blood- pressure and heart rate, and how participants tolerate the experience overall.

NCT ID: NCT02962479 Enrolling by invitation - Clinical trials for Ankylosing Spondylitis

Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?

Start date: October 2016
Phase: N/A
Study type: Observational

This study aims to compare biological communities in stool samples obtained from age, diet and BMI-matched subjects in five study groups: subjects with ankylosing spondylitis (AS) never treated with tumor necrosing factor (TNF) inhibitors, subjects with ankylosing spondylitis previously or currently treated with TNF inhibitors, subjects with non-radiographic axial spondyloarthritis (nrSpA) never treated with tumor necrosing factor (TNF) inhibitors, subjects with non-radiographic axial spondyloarthritis previously or currently treated with TNF inhibitors and healthy participants. The differences in fecal microbiota composition will be explored using shotgun metagenomic sequencing through the University of Washington. The investigators predict that this study will confirm a significant difference between the fecal microbiota composition (FMC) of both AS and nrSpA patients and controls.